TrialsgrambetaRCTs are beautiful

Glycaemic control in diabetes

Intensive vs. conventional glycaemic strategies in T1DM and T2DM, the legacy effect and the harms of over-treatment.

Trials
4
Years
1998–2008
Sort
  • 2008ACCORD Core⁠Intensive vs standard glycaemiaIn 10,251 patients with long-standing T2DM and CV disease or risk factors, intensive glucose control targeting HbA1c <6.0 % increased all-cause mortality compared with standard control (7.0–7.9 %).HR 0.9095% CI 0.78-1.04Read →
  • 2008ADVANCE⁠Intensive vs standard glycaemiaIn 11,140 patients with T2DM at high CV risk, gliclazide-based intensive control to HbA1c ≤6.5 % reduced the composite of microvascular and macrovascular events versus standard care.HR 0.90CI 0.82-0.98Read →
  • 1998UKPDS 33 Core⁠Intensive glycaemic controlIn 3,867 patients with newly diagnosed type 2 diabetes, intensive glucose control with sulfonylurea or insulin reduced microvascular endpoints compared with conventional diet-based therapy.Read →
  • 1998UKPDS 34 Core⁠MetforminIn 753 overweight patients with newly diagnosed type 2 diabetes, intensive control with metformin reduced diabetes-related endpoints and all-cause mortality compared with conventional therapy.Read →